Agree. However, it BRN might be still early. Still in a niche and the edge computing sector emerging. As far as I know from the Biotech sector, big company employees aka managers are risk averse and COA. When the wheels are starting to turn all of a sudden there is a panic run to get their hands on the new tech. And then they overpay big time. all seen in Biotech and can happen quickly.
And re Marketing, you are right again. BRN should focus on mass adoption by Samsung and/or Bosch. One POC and the run is there.
BRN Price at posting:
23.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)